Paper9388
Human adenosine deaminase. Distribution and properties.
Van der Weyden MB and 1 other. J Biol Chem, 1976. Cited by 270 papers, by iCite.
Cite this record
ConductScience Library. Human adenosine deaminase. Distribution and properties. Papers, record 9388. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9388
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenosine Deaminase | Major topic |
| Isoenzymes | Major topic |
| Nucleoside Deaminases | Major topic |
| Humans | |
| Hydrogen-Ion Concentration | |
| Kinetics | |
| Leukocytes | |
| Macromolecular Substances | |
| Molecular Weight | |
| Organ Specificity | |
| Protein Conformation |
Source PubMed
Cited by60
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 270 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40630929 | The Causal Effects Between Circulating Inflammatory Proteins and Osteoarthritis: A Mendelian Randomization and Transcriptomic Analysis. | J Pain Res | 2025 | https://conductscience.org/library/papers/40630929 | PubMed |
| 40042304 | Pharmacokinetics of islatravir in participants with moderate hepatic impairment. | Antimicrob Agents Chemother | 2025 | https://conductscience.org/library/papers/40042304 | PubMed |
| 38774877 | Clinical biomarkers for thyroid immune-related adverse events in patients with stage III and IV gastrointestinal tumors. | Front Immunol | 2024 | https://conductscience.org/library/papers/38774877 | PubMed |
| 38598538 | Multifaceted role of inosine in complex diseases and human health. | Nutr Rev | 2025 | https://conductscience.org/library/papers/38598538 | PubMed |
| 37942194 | Biomarkers for Assessment of Human Immunodeficiency Virus and its Co-Infection with Hepatitis B and Hepatitis C Viruses: A Comprehensive Review. | Iran J Pathol | 2023 | https://conductscience.org/library/papers/37942194 | PubMed |
| 37683902 | Optimized expression and purification of a human adenosine deaminase in E. coli and characterization of its Asp8Asn variant. | Protein Expr Purif | 2024 | https://conductscience.org/library/papers/37683902 | PubMed |
| 35986367 | Diversity of adenosine deaminase in children with EBV-related diseases. | Ital J Pediatr | 2022 | https://conductscience.org/library/papers/35986367 | PubMed |
| 34981765 | Catalytically active holo Homo sapiens adenosine deaminase I adopts a closed conformation. | Acta Crystallogr D Struct Biol | 2022 | https://conductscience.org/library/papers/34981765 | PubMed |
| 34881804 | Adenosine deaminase, not immune to a mechanistic rethink in central nervous system disorders? | Histol Histopathol | 2022 | https://conductscience.org/library/papers/34881804 | PubMed |
| 34654999 | Long-Term Immune Recovery After Hematopoietic Stem Cell Transplantation for ADA Deficiency: a Single-Center Experience. | J Clin Immunol | 2022 | https://conductscience.org/library/papers/34654999 | PubMed |
| 34445661 | Anti-Inflammatory Effects of Endogenously Released Adenosine in Synovial Cells of Osteoarthritis and Rheumatoid Arthritis Patients. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34445661 | PubMed |
| 33883834 | Efficiency of Galanti and Guisti Method of ADA Estimation in Comparison with the Gold Standard. | Ethiop J Health Sci | 2020 | https://conductscience.org/library/papers/33883834 | PubMed |
| 33053898 | Therapeutic Perspectives of Adenosine Deaminase Inhibition in Cardiovascular Diseases. | Molecules | 2020 | https://conductscience.org/library/papers/33053898 | PubMed |
| 31216643 | Development of a Simple Assay Method for Adenosine Deaminase via Enzymatic Formation of an Inosine-Tb3+ Complex. | Sensors (Basel) | 2019 | https://conductscience.org/library/papers/31216643 | PubMed |
| 30060448 | A Label-Free Fluorescent Assay for the Rapid and Sensitive Detection of Adenosine Deaminase Activity and Inhibition. | Sensors (Basel) | 2018 | https://conductscience.org/library/papers/30060448 | PubMed |
| 29218743 | Repeatability of pleural adenosine deaminase measurements in diagnostic evaluation of pleural effusions. | J Clin Lab Anal | 2018 | https://conductscience.org/library/papers/29218743 | PubMed |
| 27703646 | Adenosine Deaminase Activity in Chronic Lymphocytic Leukemia and Healthy Subjects. | Iran J Cancer Prev | 2016 | https://conductscience.org/library/papers/27703646 | PubMed |
| 26204249 | Mass spectrometry for the assessment of the occurrence and biological consequences of DNA adducts. | Chem Soc Rev | 2015 | https://conductscience.org/library/papers/26204249 | PubMed |
| 24887139 | Adenosine deaminase activity modulation by some street drug: molecular docking simulation and experimental investigation. | Daru | 2014 | https://conductscience.org/library/papers/24887139 | PubMed |
| 24453844 | Raised serum adenosine deaminase level in nonobese type 2 diabetes mellitus. | ScientificWorldJournal | 2013 | https://conductscience.org/library/papers/24453844 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ADA | 100 | PubTator's text mining | https://conductscience.org/library/genes/100 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9388
GET https://conductscience.org/api/papers/v1/9388/cited_by?page=2